These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

5313 related items for PubMed ID: 3409210

  • 1. Use of a tetrazolium based colorimetric assay in assessing photoradiation therapy in vitro.
    McHale AP, McHale L.
    Cancer Lett; 1988 Aug 30; 41(3):315-21. PubMed ID: 3409210
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing.
    Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB.
    Cancer Res; 1987 Feb 15; 47(4):936-42. PubMed ID: 3802100
    [Abstract] [Full Text] [Related]

  • 5. Colorimetric determination of inhibition of hematopoietic progenitor cells in soft agar.
    Horowitz D, King AG.
    J Immunol Methods; 2000 Oct 20; 244(1-2):49-58. PubMed ID: 11033018
    [Abstract] [Full Text] [Related]

  • 6. A simple in vito cytotoxicity test using the MTT (3-(4,5)-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) colorimetric assay: analysis of eugenol toxicity on dental pulp cells (RPC-C2A).
    Kasugai S, Hasegawa N, Ogura H.
    Jpn J Pharmacol; 1990 Jan 20; 52(1):95-100. PubMed ID: 2308240
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of tetrazolium-based semiautomatic colorimetric assay for measurement of human antitumor cytotoxicity.
    Heo DS, Park JG, Hata K, Day R, Herberman RB, Whiteside TL.
    Cancer Res; 1990 Jun 15; 50(12):3681-90. PubMed ID: 2340518
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of a rapid tetrazolium-based colorimetric assay for selecting anticancer drugs.
    Chen CF, Hwang JM, Wu CH, Chen CS, Chen KY.
    Zhonghua Yi Xue Za Zhi (Taipei); 1990 Jul 15; 46(1):7-16. PubMed ID: 2176928
    [Abstract] [Full Text] [Related]

  • 9. [Anticancer drug sensitivity test using the short-term microplate culture and MTT dye reduction assay].
    Hongo T, Fujii Y, Mizuno Y, Haraguchi S, Yoshida TO.
    Gan To Kagaku Ryoho; 1987 Feb 15; 14(2):472-8. PubMed ID: 2434030
    [Abstract] [Full Text] [Related]

  • 10. Ammonia-containing dimethyl sulfoxide: an improved solvent for the dissolution of formazan crystals in the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay.
    Wang H, Wang F, Tao X, Cheng H.
    Anal Biochem; 2012 Feb 01; 421(1):324-6. PubMed ID: 22100715
    [Abstract] [Full Text] [Related]

  • 11. A rapid colorimetric assay for evaluating Legionella pneumophila growth in macrophages in vitro.
    Gebran SJ, Newton CA, Yamamoto Y, Klein TW, Friedman H.
    J Clin Microbiol; 1994 Jan 01; 32(1):127-30. PubMed ID: 8126166
    [Abstract] [Full Text] [Related]

  • 12. Predictability of in vivo chemosensitivity by in vitro MTT assay with reference to the clonogenic assay.
    Shimoyama Y, Kubota T, Watanabe M, Ishibiki K, Abe O.
    J Surg Oncol; 1989 May 01; 41(1):12-8. PubMed ID: 2716329
    [Abstract] [Full Text] [Related]

  • 13. The MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay is a fast and reliable method for colorimetric determination of fungal cell densities.
    Freimoser FM, Jakob CA, Aebi M, Tuor U.
    Appl Environ Microbiol; 1999 Aug 01; 65(8):3727-9. PubMed ID: 10427074
    [Abstract] [Full Text] [Related]

  • 14. Tetrazolium-based assays for cellular viability: a critical examination of selected parameters affecting formazan production.
    Vistica DT, Skehan P, Scudiero D, Monks A, Pittman A, Boyd MR.
    Cancer Res; 1991 May 15; 51(10):2515-20. PubMed ID: 2021931
    [Abstract] [Full Text] [Related]

  • 15. A tetrazolium-based colorimetric MTT assay to quantitate human monocyte mediated cytotoxicity against leukemic cells from cell lines and patients with acute myeloid leukemia.
    van de Loosdrecht AA, Beelen RH, Ossenkoppele GJ, Broekhoven MG, Langenhuijsen MM.
    J Immunol Methods; 1994 Sep 14; 174(1-2):311-20. PubMed ID: 8083535
    [Abstract] [Full Text] [Related]

  • 16. A new 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay for testing macrophage cytotoxicity to L1210 and its drug-resistant cell lines in vitro.
    Jiao H, Shen W, Ohe Y, Miura K, Tamura T, Saijo N.
    Cancer Immunol Immunother; 1992 Sep 14; 35(6):412-6. PubMed ID: 1394344
    [Abstract] [Full Text] [Related]

  • 17. Use of an aqueous soluble tetrazolium/formazan assay to measure viability and proliferation of lymphokine-dependent cell lines.
    Buttke TM, McCubrey JA, Owen TC.
    J Immunol Methods; 1993 Jan 04; 157(1-2):233-40. PubMed ID: 8423368
    [Abstract] [Full Text] [Related]

  • 18. The use of a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide-based colorimetric assay in the viability analysis of the filamentous cyanobacterium Arthrospira platensis.
    Shiraishi H, Toyoda A.
    Biosci Biotechnol Biochem; 2021 Feb 24; 85(3):739-742. PubMed ID: 33624771
    [Abstract] [Full Text] [Related]

  • 19. Effects of the pH dependence of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide-formazan absorption on chemosensitivity determined by a novel tetrazolium-based assay.
    Plumb JA, Milroy R, Kaye SB.
    Cancer Res; 1989 Aug 15; 49(16):4435-40. PubMed ID: 2743332
    [Abstract] [Full Text] [Related]

  • 20. General Cytotoxicity Assessment by Means of the MTT Assay.
    Tolosa L, Donato MT, Gómez-Lechón MJ.
    Methods Mol Biol; 2015 Aug 15; 1250():333-48. PubMed ID: 26272156
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 266.